Identification of reduced fluoroquinolone susceptibility in Escherichia coli:: a herald for emerging resistance

被引：5

作者：

Chen, FJ ^{[1
]}

McDonald, LC ^{[1
]}

Ho, M ^{[1
]}

Lo, HJ ^{[1
]}

机构：

[1] Natl Hlth Res Inst, Div Clin Res, Taipei 11529, Taiwan

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 48卷 / 06期

关键词：

D O I：

10.1093/jac/48.6.936

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：936 / 938

页数：3

共 6 条

[1]

[Anonymous], M100S11 NCCLS

[2] Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America [J].

Gales, AC ;

Gordon, KA ;

Wilke, WW ;

Pfaller, MA ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (01) :61-64

[3]

Ho Monto, 1999, Journal of Microbiology Immunology and Infection, V32, P239

[4] Fluorcquinolone resistance in Neisseria gonorrhoeae [J].

Knapp, JS ;

Fox, KK ;

Trees, DL ;

Whittington, WL .

EMERGING INFECTIOUS DISEASES, 1997, 3 (01) :33-39

[5] Mechanisms of fluoroquinolone resistance: An update 1994-1998 [J].

Piddock, LJV .

DRUGS, 1999, 58 (Suppl 2) :11-18

[6] Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis [J].

Vasallo, FJ ;

Martín-Rabadán, P ;

Alcalá, L ;

García-Lechuz, JM ;

Rodríguez-Créixems, MR ;

Bouza, E .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :535-536

← 1 →